Allogeneic hematopoietic stem cell transplantation for NK/T-cell lymphoma: an international collaborative analysis.

Leukemia · 2023 · PMC10166457 · PMID 37157017

Europe PMC DOI

hedged sentence

0.1900

closest p · 3.8× alpha

0.1900

boldest claim

The sentences

showed a trendP = 0.19not close (p > 0.1)

While data showed a trend towards higher NRM after MAC [21.4% (95% CI: 12.4-32.1%) vs. 13.1% (95% CI: 6.0-22.9%, P = 0.19], the cumulative incidence of relapse did not show a significant difference [29.3% (95% CI: 18.7–40.7%) vs. 39.2% (95% CI: 26.7-51.4%, P = 0.29] (Table 3 ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.